Juno Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Juno Therapeutics M&A Summary

Juno Therapeutics has acquired 4 companies of its own.

Juno Therapeutics’ largest acquisition to date was in 2016, when it acquired AbVitro for $78M. Juno Therapeutics has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (75%) and information technology (25%).

Juno Therapeutics Ownership

Who owns Juno Therapeutics?

Juno Therapeutics is owned by Celgene. It was acquired on January 22, 2018.

Juno Therapeutics Business Overview

Where is Juno Therapeutics headquartered?

Juno Therapeutics is headquartered in Seattle, Washington.

How many employees does Juno Therapeutics have?

Juno Therapeutics has 373 employees.

What sector is Juno Therapeutics in?

Juno Therapeutics is a life science company.

When was Juno Therapeutics founded?

Juno Therapeutics was founded in 2013.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity4
  • Total Sectors Invested 2
  • Total Countries Invested 2

Juno Therapeutics, Inc.

307 Westlake Avenue North, Suite 300,
Seattle, Washington 98109
United States,
(206) 582-1600
www.junotherapeutics.com

Juno Therapeutics, Inc. is a biopharmaceutical company focused on revolutionizing medicine by re-engaging the body's immune system to treat cancer. Juno Therapeutics was founded in 2013 and is based in Seattle, Washington.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 4 - - - - - 4
vol $147M $147M
Sell (0.0/yr) # - - - - - - 0
  4

Most Recent M&A

Company Date Value Type
RedoxTherapies, Inc. 2016-07-14 10M USD Add-on Acquisition
Boston, Massachusetts
AbVitro, Inc. 2016-01-11 78M USD Add-on Acquisition
Boston, Massachusetts · www.abvitro.com
X-BODY, Inc. 2015-06-02 - Add-on Acquisition
Waltham, Massachusetts · www.x-bodybiosciences.com
Stage Cell Therapeutics GmbH 2015-05-11 59M EUR Add-on Acquisition
Gottingen, Germany · www.stage-celltherapeutics.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (75%) 69M (47%) - -
Information Technology 1 (25%) 78M (53%) - -
Total 4 $147M - -

By Geo

State/Country Buy Value Sell Value
United States 3 88M - -
  Massachusetts 3 88M - -
Germany 1 59M - -
Domestic 3 (75%) 88M (60%) - -
Cross-border 1 (25%) 59M (40%) - -
Total 4 $147M - -

Deal Values

buy # Total
< $100M 3 $147M
TOTAL $147M
Largest AbVitro, Inc.
$78M (2016-01-11)

 Subscribe to unlock this and 204,239
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 77K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.